Company Celsus Therapeutics PLC (ADR) Nasdaq
Equities
US15119A2024
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 01/15/01 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19/23/19 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 70 | 08/22/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01/16/01 |
Founder | 79 | 01/15/01 | |
Director/Board Member | 61 | 05/23/05 | |
Samir R. Patel
CEO | Chief Executive Officer | 55 | 29/11 |
Director/Board Member | 68 | 23/18/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 13,234,315,298 | 13,101,972,145 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
02210, Boston
+929 274 7510
http://www.akaritx.comSector
1st Jan change | Capi. | |
---|---|---|
+16.45% | 122B | |
+21.96% | 116B | |
+23.73% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.52% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |